Literature DB >> 22005475

Osteonecrosis of the humeral head in a patient with non-small cell lung cancer receiving bevacizumab.

Marianna Koczywas1, Mihaela C Cristea.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22005475     DOI： 10.1097/JTO.0b013e31822e726f

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  4 in total

1.  Long term exposure to antiangiogenic therapy, bevacizumab, induces osteonecrosis.

Authors:  Tessa Tabouret; Thomas Gregory; Marion Dhooge; Catherine Brezault; Olivier Mir; Johann Dréanic; Stanislas Chaussade; Romain Coriat
Journal:  Invest New Drugs       Date:  2015-08-28       Impact factor: 3.850

2.  Bevacizumab-associated osteonecrosis of the wrist and knee in three pediatric patients with recurrent CNS tumors.

Authors:  Jason Fangusaro; Sridharan Gururangan; Regina I Jakacki; Sue C Kaste; Stewart Goldman; Ian F Pollack; James M Boyett; Larry E Kun
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

3.  Bilateral idiopathic osteonecrosis of the major tubercle of the humerus.

Authors:  Julian Dexel; Philip Kasten
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-05-01       Impact factor: 4.342

4.  Bevacizumab-associated osteonecrosis of the femur and tibia.

Authors:  Leandro J C Oliveira; Felipe S N A Canedo; Karina P Sacardo; João V M Alessi; Felipe G Barbosa; Andrea K Shimada; Artur Katz
Journal:  Oxf Med Case Reports       Date:  2019-05-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.